Bebulin Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug should be used during pregnancy only if clearly needed.
AU TGA pregnancy category: C
US FDA pregnancy category: C
See references
Bebulin Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
Comments: The effects in the nursing infant are unknown.
The amount excreted in milk is likely to be very low since this drug is a large protein molecule. In addition, this drug is likely destroyed in the infant's gastrointestinal tract, thereby preventing any absorption.
See references
